XML 46 R38.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense

Total stock-based compensation expense recognized in the Company’s consolidated statements of operations is classified as follows:

Year ended December 31,

 

 

2024

 

 

2023

 

Cost of revenue

$

466,658

 

 

$

640,847

 

Research and development

 

 

476,666

 

 

 

617,386

 

Selling and marketing (1)

 

 

(181,160

)

 

 

266,675

 

General and administrative

 

1,103,931

 

 

 

965,501

 

Total stock-based compensation expense

$

1,866,095

 

 

$

2,490,409

 

_______________

(1)
Includes the reversal of stock compensation expense due to the departure of our Chief Marketing and Sales Officer in April 2024 and the resultant forfeiture of his unvested awards.
Schedule of Restricted Stock Units The following table shows a summary of the Company's RSUs outstanding as of December 31, 2024 as well as activity the year then ended:

RSUs

 

 

Number of Shares

 

 

Weighted Average Grant Date Fair Value

 

Unvested at December 31, 2023

 

 

22,213

 

$

208.80

 

RSUs granted

 

 

45,725

 

 

$

5.38

 

RSUs vested

 

 

(52,789

)

 

$

24.33

 

RSUs forfeited

 

 

(10,587

)

 

$

94.46

 

Unvested at December 31, 2024

 

 

4,562

 

 

$

223.07

 

The
Summary of Stock Options Activity A summary of stock option activity is as follows:

 

Number of Stock Options Outstanding

 

 

Weighted-Average Exercise Price

 

 

Weighted-Average Remaining Contractual Life (Years)

 

 

Aggregate Intrinsic Value

 

Options outstanding at December 31, 2023

 

188,865

 

 

$

74.41

 

 

 

7.9

 

 

$

 

Options granted

 

 

64,564

 

 

$

2.77

 

 

 

 

 

 

 

Options exercised

 

 

 

 

$

 

 

 

 

 

 

 

Options cancelled or forfeited

 

 

(34,999

)

 

$

152.01

 

 

 

 

 

 

 

Options outstanding at December 31, 2024

 

 

218,430

 

 

$

40.80

 

 

 

7.1

 

 

$

7,375.15

 

Options exercisable at December 31, 2024

 

 

143,214

 

 

$

49.70

 

 

 

6.1

 

 

$

7,375.15

 

Options vested and expected to vest at December 31, 2024

 

 

218,430

 

 

$

40.80

 

 

 

7.0

 

$

7,375.15

 

Summary of Assumptions Utilized for Option Grants A summary of the assumptions the Company utilized for option grants during the years ended December 31, 2024 and 2023, respectively, are as follows:

Year ended December 31,

 

2024

 

2023

Expected term (in years)

4.0

0.75-5.0

Expected volatility

 

47.8% - 55.0%

 

44.9%-47.6%

Risk-free interest rate

 

4.0% - 4.5%

 

3.8%-5.5%

Expected dividend yield

 

0.0%

0.0%